Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Panel Sequencing for Targeted Therapy Selection in Solid Tumors.

Clinics in laboratory medicine - 1 Sept 2022

Willard Nicholas, Sholl Lynette, Aisner Dara

Abstract excerpt

The genetic testing of solid tumors has evolved rapidly. With an ever-increasing number of clinically significant and/or actionable gene alterations in addition to increasing biologic, gene, or mutation-specific therapies, single-target testing is no longer suitable for many modern oncology patients. This review explores panel-based testing, including its history and evolution from prior testing modalities. We...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Mutation
Share to Neoplasms
Share to Biological Products

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Testing

Share to High-Throughput Nucleotide Sequencing

Source

Identifiers

PMID: 36150814
DOI: 10.1016/j.cll.2022.04.004

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Panel Sequencing for Targeted Therapy Selection in Solid Tumors.PMID 36150814Read ↗

Selection of Germline Genetic Testing Panels in Patients With Cancer: ASCO Guideline.Semantic proximity Read ↗

Targeted therapy according to next generation sequencing-based panel sequencingSemantic proximity Read ↗

The relative utilities of genome-wide, gene panel, and individual gene sequencing in clinical practiceSemantic proximity Read ↗

Clinical Benefit and Agenda for Clinical Sequencing Using Cancer Panel Testing: A Retrospective Clinical StudySemantic proximity Read ↗

Molecular Diagnostic of Solid Tumor Using a Next Generation Sequencing Custom-Designed Multi-Gene PanelSemantic proximity Read ↗

Molecular profiling of solid tumors by next generation sequencing and challenges faced in the healthcare settingSemantic proximity Read ↗

Molecular Testing for Stage IV Non-Small Cell Lung Cancer Patients With Targetable Mutations Following Disease Progression.Semantic proximity Read ↗

Multiplex gene-panel testing for lung cancer patients.Semantic proximity Read ↗

Clinical Utility of Large Next-Generation Sequencing Panel Across Diverse Tumour Types: A Single-Center Retrospective Analysis.Semantic proximity Read ↗

Mutation Yield of a 34-Gene Solid Tumor Panel in Community-Based Tumor Samples.Semantic proximity Read ↗

Genomic Testing in Lung Cancer: Past, Present, and Future.Semantic proximity Read ↗

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.